title: Plasma exchange therapy holds promise in the management of advanced cancer.
abstract: Cancer is now emerging as the second most common cause of death worldwide. Currently the most widely used treatments for solid cancer are surgery, chemotherapy, radiotherapy and hormone therapy, all of which are of limited effects in improvement of the survival. It is well-established that circulating factors are involved in the development of cancer. And plasma exchange is a well-established therapeutic procedure commonly used in many autoimmune diseases through the elimination of pathologic mediators, including auto-antibodies, complement components, and cytokines. Thus, we hypothesize that plasma exchange therapy alone or in combination with the routine therapeutics should be considered as an alternative for the present treatments. Future clinical studies are needed to validate the hypothesis.
authors.affiliation: Department of Stomatology, Guangzhou General Hospital of Guangzhou Military Command, 111 Liuhua Road, Guangzhou, Guangdong 510010, People's Republic of China.
authors.forename: Wei
authors.initials: W
authors.lastname: Kuang
authors.forename: Jiali
authors.initials: J
authors.lastname: Tan
authors.forename: Xiao
authors.initials: X
authors.lastname: Yuan
authors.forename: Jianmin
authors.initials: J
authors.lastname: Duan
authors.forename: Fang
authors.initials: F
authors.lastname: Jin
authors.forename: Zuolin
authors.initials: Z
authors.lastname: Jin
authors.forename: Weijian
authors.initials: W
authors.lastname: Wang
authors.forename: Xiao
authors.initials: X
authors.lastname: Li
authors.forename: Qiao
authors.initials: Q
authors.lastname: Wang
authors.forename: Yinzhong
authors.initials: Y
authors.lastname: Duan
authors.forename: Yanpu
authors.initials: Y
authors.lastname: Liu
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D010956:Plasmapheresis